All patients presented the minimum diagnostic criteria proposed by Olson et al. in 2019 (pathogenetic variants in the CDKL5 gene, severe global psychomotor retardation, and epilepsy onset in the first year of life). This evidence concerns the gene CDKL5 and epilepsy.